Patrick Keran was appointed Chief Legal Officer following the merger. Mr. Keran previously served as General Counsel of SeaSpine since 2015, secretary since 2016, and a Senior Vice President since 2020. Prior to joining SeaSpine, Mr. Keran provided strategic and business advisory services to a variety of life sciences companies, including acting as Chief Legal Officer to NAIA Pharmaceuticals, Inc., a privately held international drug development company. From 2010 to 2015, he served as President and Chief Operating Officer of Mast Therapeutics, Inc., a publicly held clinical stage biopharmaceutical company, and from 2006 to 2010, Mr. Keran served as its General Counsel. He also served as Mast’s secretary from 2006 to 2015 and served as its Principal Financial Officer from 2009 to 2013. Previously, from 2004 to 2006, Mr. Keran was associate General Counsel at Ionis Pharmaceuticals, Inc. (formerly known as Isis Pharmaceuticals, Inc.), a publicly held drug discovery and development company. From 1999 to 2004, Mr. Keran practiced corporate law at the law firms of Heller Ehrman LLP and Brobeck Phleger & Harrison LLP, specializing in public and private financings, licensing arrangements, mergers and acquisitions, and corporate governance matters. He is licensed to practice law in the State of California. Mr. Keran received a B.A. from the University of California at San Diego and a J.D. from the University of California at Berkeley, Boalt Hall School of Law.